In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
A promising therapeutic approach for Duchenne muscular dystrophy (DMD) is exon skipping using antisense oligonucleotides (AOs). In-frame deletions of the hinge 3 region of the dystrophin protein, which is encoded by exons 50 and 51, are predicted to cause a variety of phenotypes. Here, we performed...
Main Authors: | Aoki, Y, Nakamura, A, Yokota, T, Saito, T, Okazawa, H, Nagata, T, Takeda, S |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2010
|
Lignende værker
-
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
af: Aoki, Y, et al.
Udgivet: (2012) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
af: Gang Han, et al.
Udgivet: (2016-03-01) -
Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
af: Lu, Q, et al.
Udgivet: (2004) -
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
af: Lu, Q, et al.
Udgivet: (2003) -
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
af: Yin, H, et al.
Udgivet: (2009)